Banner Slide

Going further to bring better days to even more people with cancer

Our Business

The Helsinn Group is one of the world's leading supportive cancer care companies, with a comprehensive portfolio of medicines and therapies helping to improve the lives of patients in countries around the world.

Learn more

Corporate Social Responsibility and Sustainability

Sustainability is becoming an increasingly central part of Helsinn’s culture and business strategy. Integrity, quality and respect have always been at the core of our business, but increasingly, organisations are aware that they function as part of an ecosystem to which they have a responsibility. Care for the communities in which we operate, and stewardship of our environment, are as important to our long-term future as the economic bottom line.

Learn more

Our Products

The strength of the Helsinn model is reflected in the product candidates that we have transformed into sustainable market successes.

Learn more

Our Building Blocks

News & Events

Helsinn and the Scientific Centre of Monaco Sign Collaboration Agreement

Investigating the role of pharmacological inhibitors in kidney cancer

Read more

Helsinn Group and MEI Pharma Announce that Pracinostat has Received Orphan Drug ...

Lugano, Switzerland, and San Diego, USA, January 11, 2018 – Helsinn, a Swiss pharmaceutical group focused on building qu...

Read more

A call for action to patient entrepreneurs in the area of cancer to compete at t...

The Award recognizes Patient Entrepreneurs’ Innovative Efforts and Ideas for cancer and cancer supportive care using dru...

Read more

Helsinn to honor Anna Braglia Endowed Young Investigator Award recipient at Hels...

Dr. Sarah A. Buckley to be recognized as the inaugural Anna Braglia Endowed Young Investigator Award in Cancer Supportiv...

Read more

Helsinn Group supports Satellite Symposium at 10th International Conference on C...

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that it is suppo...

Read more